150 related articles for article (PubMed ID: 19405121)
1. BCL6 cooperates with CD40 stimulation and loss of p53 function to rapidly transform primary B cells.
Kusam S; Munugalavadla V; Sawant D; Dent A
Int J Cancer; 2009 Aug; 125(4):977-81. PubMed ID: 19405121
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional repressor BCL-6 immortalizes germinal center-like B cells in the absence of p53 function.
Kusam S; Vasanwala FH; Dent AL
Oncogene; 2004 Jan; 23(3):839-44. PubMed ID: 14737119
[TBL] [Abstract][Full Text] [Related]
3. Reciprocal negative regulation between the tumor suppressor protein p53 and B cell CLL/lymphoma 6 (BCL6) via control of caspase-1 expression.
Kim MK; Song JY; Koh DI; Kim JY; Hatano M; Jeon BN; Kim MY; Cho SY; Kim KS; Hur MW
J Biol Chem; 2019 Jan; 294(1):299-313. PubMed ID: 30409904
[TBL] [Abstract][Full Text] [Related]
4. Reversible disruption of BCL6 repression complexes by CD40 signaling in normal and malignant B cells.
Polo JM; Ci W; Licht JD; Melnick A
Blood; 2008 Aug; 112(3):644-51. PubMed ID: 18487509
[TBL] [Abstract][Full Text] [Related]
5. A senescence rescue screen identifies BCL6 as an inhibitor of anti-proliferative p19(ARF)-p53 signaling.
Shvarts A; Brummelkamp TR; Scheeren F; Koh E; Daley GQ; Spits H; Bernards R
Genes Dev; 2002 Mar; 16(6):681-6. PubMed ID: 11914273
[TBL] [Abstract][Full Text] [Related]
6. The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells.
Phan RT; Dalla-Favera R
Nature; 2004 Dec; 432(7017):635-9. PubMed ID: 15577913
[TBL] [Abstract][Full Text] [Related]
7. The BCL6 proto-oncogene: a leading role during germinal center development and lymphomagenesis.
Jardin F; Ruminy P; Bastard C; Tilly H
Pathol Biol (Paris); 2007 Feb; 55(1):73-83. PubMed ID: 16815642
[TBL] [Abstract][Full Text] [Related]
8. CD40-mediated apoptosis in murine B-lymphoma lines containing mutated p53.
Hollmann AC; Gong Q; Owens T
Exp Cell Res; 2002 Nov; 280(2):201-11. PubMed ID: 12413886
[TBL] [Abstract][Full Text] [Related]
9. CD40 pathway activation status predicts response to CD40 therapy in diffuse large B cell lymphoma.
Burington B; Yue P; Shi X; Advani R; Lau JT; Tan J; Stinson S; Stinson J; Januario T; de Vos S; Ansell S; Forero-Torres A; Fedorowicz G; Yang TT; Elkins K; Du C; Mohan S; Yu N; Modrusan Z; Seshagiri S; Yu SF; Pandita A; Koeppen H; French D; Polson AG; Offringa R; Whiting N; Ebens A; Dornan D
Sci Transl Med; 2011 Mar; 3(74):74ra22. PubMed ID: 21411738
[TBL] [Abstract][Full Text] [Related]
10. A signaling pathway mediating downregulation of BCL6 in germinal center B cells is blocked by BCL6 gene alterations in B cell lymphoma.
Saito M; Gao J; Basso K; Kitagawa Y; Smith PM; Bhagat G; Pernis A; Pasqualucci L; Dalla-Favera R
Cancer Cell; 2007 Sep; 12(3):280-92. PubMed ID: 17785208
[TBL] [Abstract][Full Text] [Related]
11. Regulation of bcl-xL expression and Fas susceptibility in mouse B cells by CD40 ligation, surface IgM crosslinking and IL-4.
Koizumi T; Wang J; Suzuki Y; Masuda K; Watanabe T
Mol Immunol; 1996 Nov; 33(16):1247-53. PubMed ID: 9129161
[TBL] [Abstract][Full Text] [Related]
12. Repression of the PDCD2 gene by BCL6 and the implications for the pathogenesis of human B and T cell lymphomas.
Baron BW; Zeleznik-Le N; Baron MJ; Theisler C; Huo D; Krasowski MD; Thirman MJ; Baron RM; Baron JM
Proc Natl Acad Sci U S A; 2007 May; 104(18):7449-54. PubMed ID: 17468402
[TBL] [Abstract][Full Text] [Related]
13. BCL6 controls the expression of the B7-1/CD80 costimulatory receptor in germinal center B cells.
Niu H; Cattoretti G; Dalla-Favera R
J Exp Med; 2003 Jul; 198(2):211-21. PubMed ID: 12860928
[TBL] [Abstract][Full Text] [Related]
14. A non-transgenic mouse model for B-cell lymphoma: in vivo infection of p53-null bone marrow progenitors by a Myc retrovirus is sufficient for tumorigenesis.
Yu D; Thomas-Tikhonenko A
Oncogene; 2002 Mar; 21(12):1922-7. PubMed ID: 11896625
[TBL] [Abstract][Full Text] [Related]
15. BCL6-mediated attenuation of DNA damage sensing triggers growth arrest and senescence through a p53-dependent pathway in a cell context-dependent manner.
Ranuncolo SM; Wang L; Polo JM; Dell'Oso T; Dierov J; Gaymes TJ; Rassool F; Carroll M; Melnick A
J Biol Chem; 2008 Aug; 283(33):22565-72. PubMed ID: 18524763
[TBL] [Abstract][Full Text] [Related]
16. BCL6: master regulator of the germinal center reaction and key oncogene in B cell lymphomagenesis.
Basso K; Dalla-Favera R
Adv Immunol; 2010; 105():193-210. PubMed ID: 20510734
[TBL] [Abstract][Full Text] [Related]
17. Dysregulated TCL1 requires the germinal center and genome instability for mature B-cell transformation.
Shen RR; Ferguson DO; Renard M; Hoyer KK; Kim U; Hao X; Alt FW; Roeder RG; Morse HC; Teitell MA
Blood; 2006 Sep; 108(6):1991-8. PubMed ID: 16728701
[TBL] [Abstract][Full Text] [Related]
18. BCL6 represses CHEK1 and suppresses DNA damage pathways in normal and malignant B-cells.
Ranuncolo SM; Polo JM; Melnick A
Blood Cells Mol Dis; 2008; 41(1):95-9. PubMed ID: 18346918
[TBL] [Abstract][Full Text] [Related]
19. The human programmed cell death-2 (PDCD2) gene is a target of BCL6 repression: implications for a role of BCL6 in the down-regulation of apoptosis.
Baron BW; Anastasi J; Thirman MJ; Furukawa Y; Fears S; Kim DC; Simone F; Birkenbach M; Montag A; Sadhu A; Zeleznik-Le N; McKeithan TW
Proc Natl Acad Sci U S A; 2002 Mar; 99(5):2860-5. PubMed ID: 11854457
[TBL] [Abstract][Full Text] [Related]
20. BACH2 mediates negative selection and p53-dependent tumor suppression at the pre-B cell receptor checkpoint.
Swaminathan S; Huang C; Geng H; Chen Z; Harvey R; Kang H; Ng C; Titz B; Hurtz C; Sadiyah MF; Nowak D; Thoennissen GB; Rand V; Graeber TG; Koeffler HP; Carroll WL; Willman CL; Hall AG; Igarashi K; Melnick A; Müschen M
Nat Med; 2013 Aug; 19(8):1014-22. PubMed ID: 23852341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
